S&P, Fitch, Moody’s Predict Smoother — but not Bump Free — Year for Health Insurers
-
Jan 03, 2025
In 2024, U.S. health insurers’ Medicare and Medicaid businesses began to falter after experiencing years of growth and profitability amid the country’s increasing reliance on private companies to administer the two government health care programs. Experts at credit-rating firms predict that some of those headwinds are likely to ease this year, but they probably won’t go away entirely. Meanwhile, two business lines that were safer bets for insurers last year — commercial and individual market — may face new challenges.
“We expect the industry’s operating performance will generally improve in 2025 based on Medicare Advantage repricing and product changes, as well as select county exits,” James Sung, director at S&P Global Insurance Ratings, tells AIS Health, a division of MMIT.
Read more
© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.